SABCS 2021 Conference Coverage on VuMedi

 

SABCS 2021 Conference Coverage on VuMedi
M

SABCS 2021 Update on Adjuvant Palbociclib in HR+/HER2- EBC: Final Results From the Phase III PALLAS Trial

By SABCS 2021 Conference Coverage on VuMedi FEATURING Michael Gnant
By SABCS 2021 Conference Coverage on VuMedi FEATURING Michael Gnant
0 views
December 15, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Videos
08:12
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Evaluation of Tucatinib + (Paclitaxel + Pertuzumab + Tras…

Feat. D. Potter
18:03
SABCS 2021 Conference Coverage on VuMedi

Final Findings From the CONTROL Trial of Diarrheal Prophylaxis or Ne…

Feat. C. Barcenas
11:18
SABCS 2021 Conference Coverage on VuMedi

Oral SERD Elacestrant vs. Investigator’s Choice of Endocrine Monothe…

Feat. A. Bardia
13:40
SABCS 2021 Conference Coverage on VuMedi

Optimizing Use of HER2 Therapies in MBC

Feat. P. Sharma
08:21
SABCS 2021 Conference Coverage on VuMedi

Examination of Low HER2 Expression in Breast Cancer

Feat. A. Fernandez
05:44
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 on CNS Metastases as a Site of First Recurrence in Adjuva…

Feat. N. Lin
06:59
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on the KEYNOTE-522 Trial of Neoadjuvant Pembro+Che…

Feat. P. Schmid
08:19
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Interim Analysis of the PREDICT Registry: Changes in Trea…

Feat. P. Whitworth
04:20
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 on Sacituzumab Govitecan in mTNBC: Post-Progression Thera…

Feat. J. Cortes
10:39
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 KEYNOTE-355 Final Results: Efficacy of Pembro+Chemo vs. P…

Feat. J. Cortes
09:07
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 on MRI Screening vs. SYMptom-Directed Surveillance for Br…

Feat. K. Jerzak
07:02
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Updated Results of Tucatinib vs. Placebo Added to Trastuz…

Feat. N. Lin
25:09
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 on Using the Appearance of a Resistance Mutation in Perip…

Feat. S. Vogl
32:47
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Updated Results From the RxPONDER Trial in HR+/HER2- Brea…

Feat. S. Vogl
06:26
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on the Clinical Utility of Genomic Profiling in MB…

Feat. F. Andre
11:25
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 PROs in ECOG-ACRIN EA1131: Platinum vs. Capecitabine in R…

Feat. K. Lisa Smith
14:35
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on QoL Results From OlympiA Trial: Adjuvant Olapar…

Feat. P. Ganz
10:48
SABCS 2021 Conference Coverage on VuMedi

Update on T-DXd vs. T-DM1 in HER2+ MBC: Subgroup Analyses From the P…

Feat. S. Hurvitz
06:17
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021: Does Chemotherapy Benefit Patients With HR+/HER2- ILBC?

Feat. M. Yaghi
07:16
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Results of a Prospective Screening Study: Impact of Race …

Feat. A. Barrio
24:23
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Updates on Refining Axillary Management After Neoadjuvant…

Feat. T. Mamounas
11:50
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on Samuraciclib, a First-in-Class, Oral, Selective…

Feat. C. Coombes
13:08
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…

Feat. K. Jhaveri
04:56
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on Ipatasertib + Palbociclib and Fulvestrant in HR…

Feat. M. Oliveira
07:38
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on T-DXd vs.T-DM1 in High-Risk HER2+ Residual Inva…

Feat. C. Geyer
04:45
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Presentation on the Detection of ctDNA Post Neoadjuvant C…

Feat. M. Ignatiadis
24:21
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…

Feat. A. Xu
05:24
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Detection of Early Stage BC Recurrence Using a Personaliz…

Feat. W. Janni
06:06
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 MammaPrint and BluePrint Are Prognostic of Outcome Follow…

Feat. A. Chung
12:37
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on Adjuvant Palbociclib in HR+/HER2- EBC: Final Re…

Feat. M. Gnant
08:18
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on T-DXd in Patients With HER2+ or HER2-Low-Expres…

Feat. M. Vaz Batista
19:53
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Update on IO and mTNBC: Which Chemo-Backbone and Biomarke…

Feat. R. Dent